Icodextrin Hypersensitivity in a Capd Patient

Mistry C.D. , Gokal R. , Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS study group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46(2): 496–503.

Mistry C.D. , Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int 1994; 14(Suppl 3): S158–61.

Wilkie M.E. , Plant M. , Edwards , Brown C.B. Indications and outcomes for the use of icodextrin -experience of 60 patient years (abstract). In XXXIIIrd Congress of the European Renal Association -European Dialysis and Transplant Association, June 1996. Amsterdam, Netherlands; 355.

Alsop R.M. History, chemical, and pharmaceutical development oficodextrin. Perit Dial Int 1994; 14(Suppl 2): S5–12.

Berg E.M. , Fasting S. , Sellevold O.F. Serious complications with dextran 70 despite hapten prophylaxis. Is it best avoided prior to delivery? Anaesthesia 1991; 46(12): 1033–5.

Ring J. Anaphylactoid reactions to plasma substitutes. Int Anesthesiol Clin 1985; 23(3): 67–95.